John David Hansen, PRESIDENT AND CEO at MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX), sold 366,798 shares at $0.98 ($355K) on 2018-01-11, disclosed to the SEC on 2018-01-16.
Open-market sale of $355k MBVX by PRESIDENT AND CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.96 | 110,093 | $106K | 29.8% |
| 2 | $0.96 | 110,093 | $106K | 29.8% |
| 3 | $0.98 | 64,015 | $63K | 17.7% |
| 4 | $0.98 | 64,015 | $63K | 17.7% |
| 5 | $0.96 | 18,582 | $18K | 5.0% |
| Total | $0.97 avg | 366,798 |
| $355K |
| 100% |
| Filing → |
| MBVX | SELL | 2017-04-14 | $20K | — | Filing → |
| MBVX | SELL | 2017-04-11 | $3K | — | Filing → |
| MBVX | SELL | 2017-04-06 | $11K | — | Filing → |